Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.

S. Claiborne Johnston,Pierre Amarenco,Maria Aunes,Hans Denison,Scott R. Evans,Anders Himmelmann,Marianne Jahreskog,Stefan James,Mikael Knutsson,Per Ladenvall,Carlos A. Molina,Sven Nylander,Joachim Röther,Yongjun Wang

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.

2021

S. Claiborne Johnston
Pierre Amarenco
Maria Aunes
Hans Denison
Scott R. Evans
Anders Himmelmann
Marianne Jahreskog
Stefan James
Mikael Knutsson
Per Ladenvall
Carlos A. Molina
Sven Nylander
Joachim Röther
Yongjun Wang

Background and Purpose: In patients with acute mild-moderate ischemic stroke or high-risk transient ischemic attack (TIA), the Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and ...

Keywords:

in patient
Aspirin
acute stroke
Cardiology
treatment outcome
acute ischemic stroke
Ticagrelor
benefit risk assessment
Medicine
ischemic stroke
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations